...灾害救援医学》2017年03期 【摘要】:目前,经皮冠状动脉介入治疗仍是治疗冠心病的主要手段,且药物洗脱支架(drug-eluting stents,DES)植入术是大多数行经皮冠状动脉治疗患者的首选方法。
基于104个网页-相关网页
随著涂药支架(drug-eluting stents, DES)之广泛使 用及发生晚期血栓之顾虑,aspirin并用 thienopyridine之治疗期间已建议...
基于2个网页-相关网页
随著涂药支架(drug-eluting stents, DES)之广泛使 用及发生晚期血栓之顾虑,aspirin并用 thienopyridine之治疗期间已建议...
基于2个网页-相关网页
The stated purpose of the FDA meeting is to weigh the risks and benefits of drug-eluting stents.
FDA会议的目的就是衡量药物包衣支架系统的利弊。
From 1998 to 2005 the use of equipment such as defibrillators and drug-eluting stents expanded rapidly.
从1998年到2005年,诸如心脏除颤器,药物涂层支架这样的设备普及的越来越快。
The drug-eluting stents were introduced to solve this problem by releasing a drug that prevents cell growth.
药物可释性支架可解决这一问题,它可以通过释放相关药物阻止细胞生长。
应用推荐